Search

Author/Creator Mileshkin, L

1. Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancer. (27th November 2017)

Authors:
de Boer, S M; Wortman, B G; Bosse, T; Powell, M E; Singh, N; Hollema, H; Wilson, G; Chowdhury, M N; Mileshkin, L; Pyman, J; Katsaros, D; Carinelli, S; Fyles, A; McLachlin, C M; Haie-Meder, C; Duvillard, P; Nout, R A; Verhoeven-Adema, K W; Putter, H; Creutzberg, C L
Journal:
Annals of oncology
Issue:
Volume 29:Number 2(2018)
Page Start:
424
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. LBA12Updated results of activity of durvalumab in advanced endometrial cancer (AEC) according to mismatch repair (MMR) status: The phase II PHAEDRA trial (ANZGOG1601). (24th November 2019)

Authors:
Antill, Y; Kok, P S; Stockler, M R; Robledo, K; Yip, S; Parry, M; Smith, D; Spurdle, A; Barnes, E; Friedlander, M L; Baron-Hay, S; Shannon, C; Coward, J; Beale, P J; Goss, G; Meniawy, T; Andrews, J; Kelly, M; Mileshkin, L
Journal:
Annals of oncology
Issue:
Volume 30(2019)Supplement 9
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 402 Treatment patterns post PARP inhibitor in epithelial ovarian cancer patients: results from an Australian, retrospective, multi-institute cohort study. (13th November 2020)

Authors:
Sivakumaran, T; Krasovitsky, M; Freimund, A; Chen Lee, K; Webber, K; So, J; Norris, C; Friedlander, M; Mileshkin, L; Au-Yeung, G
Journal:
International journal of gynecological cancer
Issue:
Volume 30(2020)Supplement 3
Page Start:
A166
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. 28 Prevalence and prognosis of lynch syndrome and sporadic mismatch repair deficiency in the combined PORTEC-1, -2 and -3 endometrial cancer trials. (13th November 2020)

Authors:
Post, C; Stelloo, E; Smit, V; Ruano, D; Tops, CM; Vermij, L; Rutten, TA; Jürgenliemk-Schulz, IM; Lutgens, LC; Jobsen, JJ; Nout, RA; Crosbie, EJ; Powell, ME; Mileshkin, L; Leary, A; Bessette, P; de Boer, SM; Horeweg, N; van Wezel, T; Bosse, T
Journal:
International journal of gynecological cancer
Issue:
Volume 30(2020)Supplement 3
Page Start:
A20
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Study of autologous dendritic cell therapy targeting Mucin 1 as a treatment for the maintenance of ovarian cancer patients in remission. (7th November 2013)

Authors:
Goh, J; Mason, J; Chan, J; Moradi, M; Berek, J; Beningno, B; Mileshkin, L; Recio, F; Tchabo, N; Rossi, E; Eisenberg, P; Rose, P; Mitchell, P; Young, J; Matos, M; Secord, A; Davy, M; Gargosky, S; Gray, H
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 1(2013)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗